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Abstract 
Formulation conditions have a significant influence on the degree of freeze/thaw (FT) stress-induced protein instabilities. 
Adding cryoprotectants might stabilize the induced FT stress instabilities. However, a simple preservation of protein stability 
might be insufficient and further methods are necessary. This study aims to evaluate the addition of a heat cycle following FT 
application as a function of different cryoprotectants with lysozyme as exemplary protein. Sucrose and glycerol were shown 
to be the most effective cryoprotectants when compared to PEG200 and Tween20. In terms of heat-induced reversibility 
of aggregates, glycerol showed the best performance followed by sucrose, NaCl and Tween20 systems. The analysis was 
performed using a novel approach to visualize complex interplays by a clustering and data reduction scheme. In addition, 
solubility and structural integrity were measured and confirmed the obtained results.
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Introduction
• Freezing and thawing enable a higher degree of flex-
ibility during manufacturing and improve long-term 
stability during storage [1–3]. To guarantee protein sta-
bility, chemically, mechanically, and physically induced 
stresses, including cold temperatures, have to be taken 
into account [4–7]. The influence of freezing and thaw-
ing on the protein stability is complex and depends on 
formulation parameters (buffer, excipient, and protein 
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type and concentration, pH value), system parameters 
(freezing and thawing point, glass transition and clouding 
point), and process parameters (cycle number, freezing/
thawing ramp, storage temperature and time) [4, 7–14]. 
The induced FT stress types might cause protein damage, 
which implies colloidal instabilities (aggregate forma-
tion), conformational instabilities (structural changes), 
and biological activity loss [3–5, 15, 16]. The different 
FT stress types include several processes. Freeze concen-
tration of all solutes (e.g. buffer components, excipients, 
protein) [11, 17] due to ice crystal formation. Further-
more, liquid–liquid phase separation (LLPS) might take 
place, which can be due to the increasing concentrations 
[17], and/or the decreasing temperature, also called cloud 
point  (Tcloud) [9, 18]. The decreasing temperature might 
result in cold denaturation, which is the structural loss 
of proteins with quaternary structure [19]. An additional 
issue is the growing ice surface, due to the possible dena-
turation of the protein molecules on this surface [7, 20]. 
Consequently, protein aggregates, native or non–native, 
might occur because of the mentioned effects. Protein 
aggregates can appear through different mechanisms 
[21], depending on the protein surface charge, confor-
mational changes, and excipients in the solutions. These 
parameters influence intermolecular and intramolecu-
lar interactions of proteins and/or excipients. On the 
one hand, when covalent binding (e.g. disulfide bonds) 
arises, aggregates are irreversibly bonded to each other. 
On the other hand, when non–covalent binding (e.g. elec-
trostatic, hydrophobic, van der Waals [22, 23]) occurs, 
aggregates might be reversible [21, 24–27]. Normally, 
in order to stabilize proteins in solution and to prevent 
aggregation, the formulation is adjusted using different 
excipients. To inhibit FT-induced instabilities, cryopro-
tectants are used [4, 11, 28]. The excipients, including 
cryoprotectants, show different mechanisms to stabi-
lize or destabilize proteins in solution. The excipients 
are either preferentially included or excluded from the 
proximity environment, whereas preferential exclusion, 
or hydration, results in hydration of the protein surface 
which induces a stabilizing effect [29, 30]. As a function 
of the type and strength of the resulting interactions, pro-
tein aggregates form and can be classified irreversible or 
reversible. Of special interest are reversible native aggre-
gates. Among these, one has to differentiate between 
two kinds of reversible aggregates: (a) aggregates are in 
equilibrium with monomers, and (b) induced aggregation 
by perturbation of the solution conditions (pH, tempera-
ture, etc.). The first type of aggregates (a) is reversible 
by diluting the solution, whereas for the second type of 
aggregates, (b) original solution conditions need to be re-
established. Additionally, it was shown to be possible to 
dissociate reversible protein aggregates by special treat-
ments, for example through the application of heat [26]. 
This said, heat might cause protein denaturation and/or 
induce irreversible aggregation [21]. Taken all together, 
an investigation of the reversibility/dissociability of FT 
stress-induced protein aggregates as a function of dif-
ferent excipients using heat cycling is currently missing 
and promises new insights when dealing with reversible 
aggregation during bioprocessing.
In this study the influence of different excipients, known 
to be cryoprotectants, on FT stress-induced colloidal insta-
bility on the long-term stability of lysozyme is investigated, 
whereas colloidal instability is defined as a change in the 
phase behavior and/or crystal morphology. The excipients 
chosen belong to different groups, namely two osmolytes 
(the sugar sucrose and the polyol glycerol), a polymer (poly-
ethylene glycol 200 (PEG200)), and a surfactant [Polysorb-
ate 20 (Tween20)]. Subsequently, the reversibility of these 
induced instabilities by including a heat cycle to the respec-
tive FT protocol is investigated. In order to visualize the 
occurrences, phase diagrams were chosen and systems clus-
tered using a MPPD approach. The descriptors for cluster-
ing chosen consisted out of morphological and rate values. 
Additionally, solubility and protein structure of the different 
systems were measured.
Material and methods
In this study, phase behavior, aggregation kinetics, and mor-
phology of aggregates were investigated by creating a multi-
dimensional protein phase diagram (MPPD). In addition, the 
solubility line (SL) was calculated and the colloidal stability 
(size) as well as the conformational stability (protein struc-
ture) was studied. In the following, the preparation of the 
stock solutions, the creation of the MPPD, the performance 
of the FT-cycling with and without an additional heat step, 
as well as the analytical methods used (dynamic light scat-
tering (DLS) and Fourier–transform infrared spectroscopy 
(FTIR)) are explained.
Preparation of stock solutions
For each experiment, three buffers (base buffer, salt buffer, 
excipient buffers) and a protein stock solution had to be 
prepared. As base buffer, a - mM multi-component buffer 
(MCB) was used. It was created using a tool described by 
Kröner et al. [31] and consisted of the buffer substances 
AMPSO (Sigma–Aldrich), TAPSO (Sigma–Aldrich), MES 
(AppliChem GmbH, Darmstadt, Germany), formic acid 
(Merck KGaA), and D-(+)-malic acid (Sigma–Aldrich). 
Furthermore, the pH value was adjusted, using NaOH or 
HCl (Merck KGaA), with a five-point calibrated pH meter 
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(HI-3220, Hanna® Instruments, Woonsocket, RI, USA) 
equipped with a  SenTix® 62 pH electrode (Xylem Inc., White 
Plains, NY, USA). The pH value was adjusted to a value dif-
fering by up to ± 0.1 pH units from the final pH value. Prior 
to the use of the buffer, the pH value was verified again 
and finally adjusted to a value differing by only ± 0.02 pH 
units. In addition, the ionic strength (IS) was adjusted to 
10.08 ms/cm with an accuracy of ± 1 ms/cm at 24 °C ± 1 °C 
using the conductivity meter CDM 230 (Radiometer Ana-
lyticals, Lyon, France) and the four-point calibrated con-
ductivity cell E61M014 (Radiometer Analyticals, Lyon, 
France) using NaCl (Merck KGaA). A salt buffer with dif-
ferent concentrations, 2.0 M, 3.75 M, and 4.29 M, was pre-
pared. The respective amount of NaCl (Merck KGaA) was 
dissolved in the base buffer. The same procedure was per-
formed on the excipient buffer. Stock excipient buffer with 
1.8 M sucrose (Sigma-Aldrich), 3 M glycerol (VWR, Rad-
nor, PA, USA), 84 mM polyethylene glycol 200 (PEG200)
(Sigma-Aldrich), and 0.72 mM polysorbate 20 (Tween20) 
(AppliChem GmbH) were prepared. The pH values of all 
additives (salt, and excipient) were adjusted on the day of 
preparation and prior to use as described above. All buffers 
were filtered through a 0.2-µm  Supor® Polyethersulfone (Pall 
Corporation, Port Washington, NY, USA) filter and stored 
at room temperature. The buffers were not used for longer 
than 2 weeks after preparation. The protein stock solution 
was prepared with lyophilized lysozyme from chicken egg 
white (Hampton Research, Aliso Viejo, CA, USA).
The protein was dissolved in the base buffer and filtered 
through a 0.2-µm syringe cellulose acetate filter (VWR). 
A desalting step was attached to remove aggregates and 
production-related additives, using PD-10 (GE Healthcare, 
Uppsala, Sweden) columns and the respective spin proto-
col [32]. To adjust the final protein concentration of 87 mg/
mL, a 1:10 dilution was prepared and measured using the 
NanoDrop™ 2000c UV–Vis spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA, USA). Thereby, an extinc-
tion coefficient of  E1% (280 nm) = 22.00 Lg/cm was used for 
the measurement. The protein stock solution was prepared 
freshly and was not used for more than one day.
Phase diagrams
To create the phase diagrams, a method described by Baum-
gartner et al. was used [33]. The final lysozyme concen-
trations varied between 2.5 mg/mL and 25 mg/mL, and 
the final NaCl concentrations between 0 M and 2.5 M. 
The excipient concentration was kept constant at 300 mM 
sucrose, 1000 mM glycerol, 6.8 mM PEG200 or 0.03 mM 
Tween20. The protein and salt stock solutions were placed 
onto a Freedom EVO® 100 fully automated liquid handling 
station (Tecan Group Ltd., Männedorf, Switzerland) plat-
form. The liquid handling station is equipped with fixed tips 
and 250 µL dilutors and controlled by Freedom  EVO® 2.4 
SP3 (Tecan Group Ltd.). The protein and salt concentra-
tion dilution rows were prepared in a Deepwell PP plate 
(Greiner Bio-one, Frickenhausen, Germany). After the salt 
dilution row was prepared, either 57.2 µL of sucrose or 
glycerol or 25 µL of PEG200 or Tween20 was added and 
mixed manually. Then, the phase diagram was created auto-
matically in a MRC Under Oil 96–well Crystallization Plate 
(SWISSCI AG, Neuheim, Switzerland), whereas 18 μL of 
the salt/additive solution was mixed with 6 μL protein solu-
tion. Before the plates were sealed with  Duck® Brand HD 
Clear sealing tape  (ShurTech® brands, Avon, OH, USA), 
to avoid evaporation, plates were centrifuged in an Eppen-
dorf centrifuge 5810 R (Eppendorf AG, 100 Hamburg, 
Germany) at 1000 rpm for 1 min to remove all air bubbles. 
After performing the FT protocols with and without heat 
cycling (“Cycling”), the plates were placed in the incubation 
chamber RockImager 54 (Formulatrix, Bedford, MA, USA) 
at 20 °C for 40 days.
Cycling
FT cycling
FT protocol with different cycles numbers (FT cx; x = 0, 1, 
3) were carried out. A plate at FT c0, not subjected to any 
FT stress application, was used as a reference plate. This 
plate was directly placed into the incubation chamber after 
preparation. The other plates were placed onto the cryogenic 
device EF600M 105 (Grant Instruments, Cambridgeshire, 
UK) after preparation. The plate handling and the adjust-
ments on the cryogenic device are described in the publica-
tion by Wöll et al. [13]. In this study, all plates were frozen 
at 0.5 ℃/min and thawed at 2.5 ℃/min.
Heat cycling
Heat cycling following FT cycling was performed (FT cy 
h; y = 1, 3) as follows: The respective plates were heated to 
40 ℃ for 30 min using a HLC Cooling-ThermoMixer MKR 
13 (Ditabis AG, Pforzheim, Germany). Upon completion, 
the plates were directly placed in the incubation chamber 
at 20 ℃.
Multidimensional protein phase diagrams (MPPD)
To evaluate phase transitions, long-term stability and 
reversibility of aggregates of the used lysozyme formula-
tion, an MPPD was employed [33]. An MPPD combines 
data on morphology, kinetic and aggregation obtained 
from images taken during storage, in one figure by data 
reduction and subsequent clustering. In this study, the fol-
lowing data were extracted manually from the images: (1, 
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2) length and width of a maximum of eight crystals in 
µm, (3) percentage aggregation amount per well (nAgg), 
(4) aggregation onset time (tonset) in hours, and aggregation 
growth time (tG) in hours. The mean crystal 120 length 
(LC) and width (WC) as well as the interquartile range 
(IQR) of the crystal lengths (∆LC) and widths (∆WC) were 
calculated. In addition, the ratio of the length and width 
(LC: WC) and the interquartile range of this ratio [∆(LC: 
WC)] were calculated. Using all of these mentioned param-
eters, the MPPDs were constructed. The used settings for 
the MPPD construction have been described in a previ-
ous work [34], where the clustering algorithm selected 
an optimal cluster number between three and ten clusters.
In addition, to evaluate the occurrence of each cluster, 
the total amount of each cluster per phase diagram was 
determined and the occurrence in percentage per plate was 
calculated.
Analytics
In order to evaluate if structural parameter alter due to 
(a) initial stress and (b) heat reversibility, FTIR and DLS 
measurements were applied. Stable conditions were chosen 
at 18 mg/mL and 22 mg/mL at the four lowest salt con-
centrations (0.00, 0.23, 0.45, and 0.68 M). A condition 
was only analyzed when no visible aggregation appeared 
prior to the actual measurement (tonset > t0). This resulted 
in a total amount of 151 samples (non-stressed (FT c0), 
stressed (FT c1 and FT c3), stressed and heated (FT c1 h 
and FT c3 h). In addition, supernatant measurements of 
all phase diagrams were performed to calculate SLs. The 
protein stock solution for the analytics was prepared as 
described in “Preparation of stock solutions”. The pipet-
ting was performed manually, whereas the protein, salt, and 
excipient solutions were mixed in the same ratio as was done 
for the phase diagrams, see “Phase diagrams”. A maximum 
of 180 µL of the samples was prepared in 0.5 mL Eppen-
dorf tubes (Eppendorf AG). For the stressed samples (FT cx; 
x = 1, 3 and FT-heating FT cy h; y = 1, 3), the samples were 
split into up to six 30 µL proportions and pipetted in the 
crystallization plate, after preparation in 0.5 mL Eppendorf 
tubes (Eppendorf AG). Afterwards, plate handling was done 
as described in “Phase diagrams” and “Cycling”. After the 
respective stress protocol was performed, the samples were 
pipetted back into Eppendorf tubes and mixed. Before the 
analytical method could be performed, the samples were 
filtered, using an Eppendorf centrifuge 5810 R (Eppendorf 
AG) at 2000 g for 5 min, through a 0.2-µm AcroPrep™ 96 
filter plate (350 µL)(Pall Corporation, New York, New York, 
USA) into a 96–well PP-Microplate (U-shape)(Greiner Bio-
one). After filtration, the samples were split to be used with 
the different analytical methods which are described below.
Dynamic light scattering (DLS)
The hydrodynamic radius of the protein in the respective 
solution was measured with DLS using the Wyatt DynaPro 
Plate Reader I (Wyatt,Santa Barbara, California, USA) and 
a polystyrene 384-well assay plate (Corning Inc., Corning, 
New York, USA). Therefore, 25 µL of the filtered sample 
was pipetted into the wells in triplicate and was covered 
with 10 µL Xiameter™ PMX-200 Silicon fluid 20cs (Dow 
Corning Inc. Midland, Michigan, USA) to avoid evapora-
tion. The plate was centrifuged in an Eppendorf centrifuge 
5810 R (Eppendorf AG) at 400 g for 1 min to remove all air 
bubbles. Next, the plate was placed in the plate reader and 
each sample was measured twice at 20 ℃ with an acquisi-
tion time of 5 s and an acquisition number of 10 as well as 
automatic attenuation.
Fourier‑transform infrared spectroscopy (FTIR)
To investigate changes in the secondary protein structure 
FTIR spectroscopy, a Tensor 27 (Bruker Optics, Ettlin-
gen, Germany) was used. The FTIR was equipped with a 
cryo-cooled mercury cadium telluride (CC-MTC) narrow 
detector (Bruker Optics) and a BioATR II crystal (Bruker 
Optics) and controlled by OPUS 7.2 (Bruker Optics). For 
the measurement, 25 µL of background or sample was pipet-
ted onto the crystals, covered with a lid, and then measured 
for 5 min (mirror speed of 160 kHz) with a resolution of 
2 cm−1 in a range from 3500 to 900 cm−1. The background 
subtraction, as well as automatic compensation, was auto-
matically performed by the software. Additionally, data pre-
processing was performed. After atmospheric compensation 
and vector normalization, the data were smoothed using a 
Savitzky–Golay filter with a second-order polynomial and 
a frame length of 17 in a wavenumber region from 1750 to 
1550 cm−1. This data were then used to calculate the average 
of the samples measured in duplicate. The area within the 
amid I range (1600–1700 cm−1) for the α-helix, β-sheet, and 
β-sheet antiparallel was extracted using the trapz function 
available in MATLAB (Version 2019b). Therefore, the peak 
minimum for α-helix (1650–1685 cm−1), β-sheet antiparal-
lel (1670–1685 cm−1), and the peak maximum for β-sheet 
(1615–1635 cm−1) was detected, using the function peakdet 
available in MATLAB (Version 2019b). The area was then 
calculated at the interval of the min/max peak ± 2 cm−1.
Solubility line (SL)
For determining the SLs, the supernatant of the phase dia-
grams was measured. For this purpose, 3 µL of the super-
natant of each condition was carefully (no air bubbles, no 
visible aggregates) pipetted on the NanoDrop™ 2000c, and 
the concentration measured in triplicate. Afterwards, the 
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solubility lines were calculated using a method published 
by Galm et al. [35]. For this study, the conditions with crys-
tals were taken into account. Furthermore, the curves were 
integrated, using the function integral available in MATLAB 
(Version 2019a), and the areas from 0 M to 2.5 M salt and 
from 0 mg/mL to 25 mg/mL protein were calculated.
Results
This aim of the study was to evaluate the following: (a) 
whether the influence of different excipients on the long-
term protein stability of FT stressed formulations can be fol-
lowed by the creation of MPPDs and (b) whether the induced 
instabilities are reversible by a simple heat treatment.
The model system used to perform this investigation con-
sisted of chicken egg white lysozyme, different amounts of 
NaCl and cryoprotectant. The protein concentrations ranged 
from 2.5 to 25 mg/mL at pH 5. The NaCl concentration as 
precipitant was increased up to 2.5 M. Four different cryo-
protectants (a) 300 mM sucrose, (b) 1000 mM glycerol, (c) 
6.81 mM PEG200, and (d) 0.03 mM Tween20 in a solution 
containing NaCl were added to this model system separately. 
Different FT cycle numbers (FT cx; x = 0, 1, 3), as well as 
a heat cycle (FT cy h; y = 1, 3), were performed for each of 
the formulations during the study.
Multidimensional protein phase diagram (MPPD)
Overall, 2400 different formulations were studied and 
resulted in different phase states, soluble and crystalline 
(exemplary pictures see Fig. 1). To visualize all morpholo-
gies and kinetic data in one figure, the MPPD construction 
includes a data reduction step. This reduction step results 
in an energy value of 95.5%, which indicates an informa-
tion loss of 4.5%. An optimal number of seven clusters was 
obtained when the reduced dataset was clustered; they are 
shown as radar charts (I-VII) in Fig. 2a. Each radar chart 
represents a specific combination of image-based features: 
the crystal length (LC) and widths (WC), variation in crys-
tal length (∆LC) and width (∆WC), the aggregation amount 
(nagg), the aggregation onset time (tonset), and aggregation 
growth time (tG), as well as the ratio of crystal length and 
width (LC: WC), and the variation of this ratio [∆(LC: WC)]. 
The normalized median values are visualized as a colored 
surface, and the corresponding median absolute deviation 
(MAD) is shown as a dashed line in Fig. 1. An overview of 
the absolute values, representing the median ± MAD, which 
is calculated based on all formulations within the mentioned 
cluster, and their ranges of each cluster is given in Table 1.
Cluster I (Cl I) represents soluble conditions, all values of 
the image features are equal to zero, as no aggregation took 
place. However, for some conditions, which were clustered 
to Cl I, aggregates were observed. These conditions were 
analyzed manually and are bordered by dashed lines in 
Fig. 2. Cl  II represents a few (nagg = 10 ± 7%) relatively 
large (LC = 202 ± 186 µm and WC = 141 ± 124 µm) crystals 
which have an onset time after a few hours (tonset = 6 ± 9 h) 
but a very long growth time (tG = 892 ± 95 h). An exem-
plary picture of such a crystal is shown in Fig. 1. Cl III 
represents crystals which show a slightly higher amount 
(nagg = 15 ± 7%) and an earlier crystal growth onset 
time (tonset = 1 ± 1  h) as well as a shorter growth time 
(tG = 456 ± 142 h). Within Cl IV and Cl V the amount of 
crystals increased to nagg = 25 ± 7% / 77 ± 11%, and the 
crystal size decreased significantly to LC = 32 ± 14 µm / 
34 ± 11 µm and WC = 24 ± 10 µm / 25 215 ± 8 µm, receptively 
(see Table 1 and Fig. 1). Whereas Cl IV indicated two dif-
ferent morphologies: tetragonal crystals and densely grown 
micro crystals (see Fig. 1). The tetragonal crystals grew 
preferably when no stress was applied, whereas the micro 
crystals grew after FT stress was applied. Cl VI showed a 
significant higher crystal growth time (tG = 620 ± 208 h) 
and a significant increased ratio between crystal width and 
length (LC:WC = 7.8 ± 9.3). This cluster also represented two 
types of crystal morphologies: sea urchin crystals and small 
tetragonal crystals. The sea urchins are dominant in the 
supersaturated region, and the small tetragonal crystals grow 
at lower salt and protein concentrations. Cl VII showed the 
highest values for the crystal length and the ratio between 
crystal length and width, as well as crystal growth time 
(LC = 915 ± 380 µm, LC:WC = 76.4 ± 37.9, tG = 783 ± 195 h).
Formulations
The results of the long-term storage experiment are pre-
sented in the MPPD in Fig. 2, where lysozyme was moni-
tored for 40 days at 20 °C using 2400 different formulations. 
The different columns (C 1–5) in Fig. 2a represent the differ-
ent formulations with NaCl (C 1), NaCl + 300 mM sucrose 
(C 2), NaCl + 1000 mM glycerol (C 3), NaCl + 6.81 mM 
PEG200 (C  4), and NaCl + 0.03  mM Tween20 (C  5), 
whereas the different rows (R 1–5) represent the different 
cycles performed [FT c0, FT c1, and FT c3 (R 1–3)] and the 
combination of FT stress followed by a heat cycle [FT c1 h 
and FT c3 h (R 4–5)]. Figure 2b summarizes the percentages 
occupied by the different clusters for each system.
Initial state–FT c0
NaCl All clusters were present at FT c0, whereas Cl II and 
Cl III were dominant in the transition zone from the soluble 
(Cl I) to the aggregation zone, see Fig. 2a, R1. Increasing the 
NaCl and lysozyme concentration resulted in Cl IV, Cl V, 
and Cl VI. At the highest lysozyme concentrations (23 mg/
mL and 25 mg/mL) and NaCl concentrations (2.27 M and 
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2.5 M), Cl VII appeared. The overall contribution of the dif-
ferent clusters were for Cl  I 47.92%, Cl  II 15.63%, Cl  III 
20.83%, Cl IV 8.33%, Cl V 2.08%, Cl VI 6.25%, and Cl VII 
4.17%, see Fig. 2b, R 1 and C 1.
Sucrose Adding sucrose to the formulations, the aggrega-
tion zone slightly decreases for FT c0, and Cl V and VI dis-
appeared, see Fig. 2a, C 2. Cl IV was present at lysozyme 
concentrations above 18  mg/mL and NaCl concentrations 
between 1.14 M and 2.05 M. The transition zone from the 
soluble zone (Cl  I) to the aggregation zone consisted of 
Cl II and Cl III. Cl VII was present at the highest lysozyme 
and NaCl concentrations. The overall contribution of the 
different clusters was for Cl I 41.67%, Cl II 16.67%, Cl III 
20.83%, Cl IV 8.33%, Cl V 2.08%, Cl VI 6.25%, and Cl VII 
4.17%, see Fig. 2b, R 1 and C 2.
Glycerol Replacing sucrose by glycerol in the formulation 
resulted in a smaller aggregation zone/larger soluble zone 
(Cl I) compared to pure NaCl formulations for FT c0. In the 
transition zone to Cl I was still created out of Cl II and Cl III, 
whereas it was smaller compared to NaCl formulations. In 
the remaining aggregation zone, Cl  IV was dominant, see 
Fig. 2a, C 3. The overall contribution of the different clus-
ters were for Cl I 47.92%, Cl II 13.54%, Cl III 8.33%, Cl IV 
26.04%, and Cl V 4.17%, see Fig. 2b, R 1 and C 3.
PEG200 PEG200 formulations showed phase behaviors 
very similar to those of NaCl formulations, see Fig. 2a, C 4. 
In the transition zone from the soluble zone (Cl  I) to the 
aggregation zone, Cl  II, and at increasing protein and salt 
concentrations, Cl III was dominant up to a NaCl concen-
tration of 1.82 M. In the high concentration region, mainly 
Fig. 1  The clusters detected for the data set are shown with the 
respective example pictures of exemplary crystals. The color surface 
in the radar charts represents the normalized median values of each 
image feature. The following image–based features were used for the 
clusters: the crystal length (LC) and widths (WC), the IQR of the crys-
tal length (ΔLC) and width (ΔWC), the aggregation abundance (nAgg), 
the aggregation onset time (tonset), and aggregation growth time (tG), 
as well as the ratio of crystal length and width (LC:WC), and the IQR 
of this ratio [Δ (LC:WC)]. The median absolute deviation within each 
cluster for each image–based feature is shown by a dashed line in the 
radar charts. The absolute cluster values can be found in Table 1. The 
exemplary crystal pictures are made with visible light. Soluble condi-
tions were presented by Cl I, tetragonal crystals are presented by Cl 
II, complex structured crystals by Cl III, either tetragonal crystals at 
FT c0 (top) or dense grown micro crystals with FT stress (bottom) by 
Cl IV, micro crystals by Cl V, sea urchin (top) and small tetragonal 
crystal (bottom) by cluster VI, and sea urchin crystals by Cl VII
1315Bioprocess and Biosystems Engineering (2020) 43:1309–1327 
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Fig. 2  In A the MPPDs for five different lysozyme formula-
tions (NaCl, NaCl + sucrose, NaCl + glycerol, NaCl + PEG200, 
NaCl + Tween20 (C 1–5)) and different stress protocols (R 1–5). The 
lysozyme concentration [mg/mL] was varied over the NaCl concen-
tration [M]. Seven clusters were identified and used for the MPPD 
using the mean cluster color and cluster number similar to the radar 
charts, shown in Fig. 1. In B the calculated occurrence in [%] of each 
cluster per phase diagram is shown with the respective values
1316 Bioprocess and Biosystems Engineering (2020) 43:1309–1327
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Cl VI and VII were created. The overall contribution of the 
different clusters were for Cl I 42.71%, Cl II 25.00%, Cl III 
17.71%, Cl IV 1.04%, Cl V 1.04%, Cl VI 8.33%, and Cl VII 
4.17%, see Fig. 2b, R 1 and C 4.
Tween20 For Tween20 formulations Cl V was most domi-
nant at FT c0, see Fig. 2a, C 5. The occurrence of Cl I was 
slightly lower compared to that of the NaCl formulations. 
The overall contribution of the different clusters were for 
Cl I 43.75%, Cl II 7.29%, Cl III 7.29%, Cl IV 11.46%, Cl V 
28.13%, and %, Cl VI 2.08%, see Fig. 2b, R 1 and C 5.
FT cycles–FT c1and FT c3
In general increasing the number of FT cycles resulted in a 
decrease in the Cl I region (soluble region) for all formula-
tions tested; see Fig. 2b, R 1–3. The more FT cycles were 
applied, the higher the amount of Cl IV was observed.
NaCl NaCl formulations showed an increase of condition 
belonging to Cl  IV when increasing the cycle number, 
8.33% to 13.54% to 30.21%, see Fig. 2b, C 1. Cl IV at FT c1 
was created at lysozyme concentrations higher than 21 mg/
mL up to 1.59 M NaCl. At FT c3 the region expanded and 
Cl  IV was dominant at all lysozyme concentrations up to 
1.59 M NaCl, see Fig. 2a, R 3. Considering that, the higher 
the lysozyme concentration, the more salt had to be added to 
create Cl IV. At high supersaturations, still Cl VI and Cl VII 
were dominant for FT c1 and FT 3.
Sucrose Sucrose formulations do also show a cluster trans-
formation to Cl IV and Cl V by increasing the cycle number, 
see Fig. 2a, C 2. The occurrence of these clusters increased 
from 17.71% to 28.13% to 27.08% for Cl IV and from 0% 
to 8.33% to 19.97% for Cl V while increasing the number 
of cycles, see Fig. 2b, R 1–3 C 2. Regarding the positions 
of the clusters, the Cl IV region is spilt by Cl V, see Fig. 2a, 
C  2. The occurrence of Cl  VII stayed the same (8.5%), 
whereas the region with Cl II and Cl III decreased signifi-
cantly. For Cl II the occurrence decreased from 15.63% to 
4.17% to 2.08% and for Cl II from 10.42 to 8.33% for FT c1 
and FT c3, see Fig. 2b, C 2. The Cl I zone, however, was not 
significantly decreased at FT c1, compared to NaCl formu-
lations, only slightly decreased at FT c3 (47.92% to 42.71% 
to 33.33%).
Glycerol Formulations containing glycerol showed a signif-
icant increase of Cl II from FT c0 to FT c1, 13.54–32.29%, 
respectively, see Fig. 2a, C 3 and Fig. 2b, C 3. At FT c3 a 
cluster transformation to mainly Cl IV (46.88%) took place. 
The Cl I region was slightly decreased when the number of 
cycles was increased (47.92% to 36.46% to 32.29%).
PEG200 PEG200 formulations showed the same cluster 
transition as NaCl formulations, see Fig. 2a, C 4. Concern-
ing the occurrence of the clusters small differences were 
seen. When the formulations were stressed, the occurrence 
of Cl IV was dominant, whereas Cl II and Cl III were less 
present compared to NaCl formulations. At FT c3 44.79% of 
the conditions belong to Cl IV, whereas only 30.21% belong 
to this cluster when only NaCl was in the formulation, see 
Fig. 2a, C 4 and b, C 4.
Tween20 Tween20 formulation did show a cluster transfor-
mation to Cl IV from FT c0 with an occurrence of 11.46% 
to FT c1 with an occurrence of 69.79%. To FT c3 the occur-
rence of Cl  IV slightly increased to maximum of 73.96%, 
see Fig.  2a, C  5 and Fig.  2b, C  5. The occurrence of the 
soluble zone (Cl I) decreased significantly from 43.75% at 
FT c0 to 25.00% at FT c1 and FT c3.
Heat cycle–FT c1 h and FT c3 h
The reversibility regarding the phase state (soluble/aggre-
gate) and the occurrence of Cl II and Cl III were analyzed. 
In general, the additional heat cycle increases the Cl I region 
compared to the corresponding FT cycles, see Fig. 2a R 4–5.
NaCl For NaCl formulations similar positions of the clus-
ter at FT  c1  h and FT  c3  h compared to FT  c0 could be 
Table 1  Overview of median 
± median absolute deviation 
(MAD) image-based feature 
values. The values are listed per 
cluster identified in the separate 
multidimensional protein phase 
diagram
I II III IV V VI VII
LC [µm] 0 ± 0 202 ± 186 192 ± 209 32 ± 14 34 ± 11 105 ± 92 915 ± 380
WC [µm] 0 ± 0 141 ± 124 139 ± 150 24 ± 10 25 ± 8 16 ± 9 13 ± 4
LC:WC [–] 0 ± 0 1.4 ± 0.2 1.3 ± 0.2 1.3 ± 0.1 1.4 ± 0.1 7.8 ± 9.3 76.4 ± 37.9
tonset [hours] 0 ± 0 6 ± 9 1 ± 1 0 ± 0 0 ± 0 0 ± 0 0 ± 0
tG [hours] 0 ± 0 892 ± 95 456 ± 142 12 ± 15 16 ± 19 620 ± 208 783 ± 195
nagg [%] 0 ± 0 10 ± 7 15 ± 7 25 ± 7 77 ± 11 60 ± 22 75 ± 22
∆LC [µm] 0 ± 0 51 ± 52 52 ± 56 11 ± 7 11 ± 6 37 ± 35 1032 ± 529
∆WC [µm] 0 ± 0 46 ± 49 48 ± 58 9 ± 6 8 ± 4 7 ± 5 6 ± 4
∆(LC:WC) [−] 0 ± 0 0.3 ± 0.3 0.4 ± 0.3 0.3 ± 0.2 0.4 ± 0.2 3.3 ± 4.2 93.2 ± 43.4
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observed. Regarding the reversibility of the phase states, 
the occurrence of Cl  I reached values similar to those at 
FT c0 (41.67%) at FT c1 h with 45.83% and at FT c3 h with 
39.58%, see Fig. 2a, C 1 and Fig. 2b, C 1. The occurrence of 
Cl II and Cl III did not significantly change between all the 
cycles applied. The Cl II and Cl III appeared again adjacent 
to Cl I as it was the case for FT c0, when a heat cycle was 
performed.
Sucrose When sucrose was added to the formulations and 
heat cycling was performed after the formulations were 
FT–stressed, a significant zone of Cl II was created in zone 
adjacent to Cl I which was not the case at FT c1 and FT c3, 
see Fig. 2a, C 2. The occurrence of these clusters was very 
low at FT c1 and FT c3, but Cl II reached a similar occur-
rence compared to FT c0 (16.67%), when a heat cycle was 
performed (FT c1 h 13.54%, FT c3 h 15.63%), see Fig. 2b, 
R 4–5 and C 2. The occurrence of Cl I increased significantly 
for FT c1 h and FT c3 h (45.83% and 39.58%) compared 
to the respective systems at FT c1 and FT c3 (33.33% and 
25.00%), whereas nearly the same occurrence as at FT c0 
(41.67%) with sucrose were reached, see Fig. 2a, C 2 and 
Fig. 2b, C 2.
Glycerol Applying a heat cycle to glycerol formulations 
after they were stressed with freezing/thawing resulted in 
an appearance of the same clusters as occurred at FT c0, as 
well as the position of these clusters are similar, see Fig. 2, 
C 3. Concerning the occurrence of Cl I, the same occurrence 
as at FT c0 (47.92%) could be reached at FT c3 h (47.92%) 
and was even increased at FT c1 h (54%). In addition the 
occurrence of Cl  II and Cl  III (FT  c1  h 17.71%/11.46%, 
FT  c3  h 14.58%/3.13%) reached values close to those at 
FT c0 (Cl II 13.54%, Cl III 8.33%), with the exception of 
Cl III at FT c3 h (3.31%), see Fig. 2b R 4–5 and C 3.
PEG200 The addition of a heat cycle to PEG200 formula-
tions resulted in a similar positioning of the Cl II and Cl III 
region compared to FT c0, which was adjacent to Cl I. Nev-
ertheless, this region was significant at FT c1 h (Cl II 7.29%, 
Cl III 8.33%) and FT c3 h (Cl II 9.38%, Cl III 5.21%) smaller 
than at FT c0 (Cl II 25.00%, Cl III 17.71%), see Fig. 2a, C 4 
and Fig. 2b. The occurrence of Cl I for FT c1 h (33.33%) and 
FT c3 h (34.38%) only reached values of FT c1 (31.25%) 
and not the one of FT c0 (42.71%).
Tween20 The heat cycle influenced only the occurrence of 
Cl I for Tween20 formulations and not the cluster formation 
itself. Still mainly Cl  IV was observed like at FT  c1 and 
FT c3. At FT c1 h a similar occurrence of 40.63% of Cl I 
compared to FT c0 with 43.75% could be observed. FT c3 h 
showed a slightly smaller occurrence of Cl I with 35.42% 
compared to FT c0, see Fig. 2a, C 5 and Fig. 2b, C 5.
Formulation comparison
Adding different excipients to a NaCl phase diagram resulted 
in a different phase behavior for each excipient, see Fig. 2a, 
R 1/C 1–5. In the following, a comparison with a focus of 
the effects arising from the different excipients is laid for 
the initial state and the different cycles studied. In general, 
the influence of FT cycles and the reversibility by heat is 
strongly dependent on the cryoprotectant.
Initial state–FT c0 In the transition zone to Cl I for all for-
mulations, Cl II and Cl III are present, whereas for Tween20 
formulations, the region is very small. Regarding the size 
of the Cl I region, NaCl and PEG200 formulations showed 
a slightly smaller region than formulations containing 
sucrose, glycerol or Tween20, see Fig. 2b, R 1. Cl VII was 
only created in the highly concentrated region for NaCl, 
sucrose and PEG200 formulations.
FT cycle–FT c1 and FT c3 The influence of the FT cycles, as 
well as the phase behavior at FT c0, were very similar for 
NaCl and PEG200 formulations. The position of the clusters 
changed similar when FT stress was applied, see Fig.  2a, 
R 1–3, C 1 and C 4. The occurrence of Cl I was highest with 
sucrose and glycerol formulations compared to the other 
formulations tested, see Fig. 2b. Furthermore, the FT stress 
did not have such a significant impact on the occurrence of 
Cl II for sucrose and glycerol formulations. In general, the 
higher the cycle number, the lower the occurrence of Cl I. 
For Tween20 formulations there was no difference between 
FT c1 and FT c3 regarding the Cl I occurrence visible, see 
Fig. 2b, R 1–3.
Heat cycle–FT c1 h and FT c3 h When a heat cycle was per-
formed the increase of the Cl  I region when a heat cycle 
was added was less pronounced for PEG200 and Tween20 
formulations compared to the other formulations tested. 
All formulations showed cluster transformation back to 
the clusters seen at FT c0, with the exception of PEG200 
and Tween20 formulations, see Fig. 2a, R 4–5 and Fig. 2b, 
R 4–5. With a heat cycle, Cl V occurred for PEG200 for-
mulations, which was not seen at any other system with 
PEG200 formulations. With Tween20 the heat cycle only 
influenced the occurrence of Cl I and did not result in a clus-
ter transformation at all.
Analytics
Information of three different analytic methods: (1) protein 
solubility (SL), (2) protein size (DLS) and (3) protein struc-
ture (FTIR) were added to the MPPDs. These measurements 
were performed for two reasons: (a) to evaluate if initial 
stress leads to changes in structural parameter or size of the 
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proteins under investigation and (b) to evaluate if the process 
exploiting heat reversibility leads of structural (FTIR) or size 
(DLS) based alterations.
Solubility line (SL)
To investigate the protein solubility, supernatant meas-
urements of each phase diagram were performed and SLs 
were calculated, as described in “Solubility line (SL)” and 
presented in Fig. 3a. To identify more easily differences 
of the SLs, the area was calculated underneath the curves 
as described in “Solubility line (SL)”. Bar graphs of these 
values are shown in Fig. 3b. The trend regarding the influ-
ence of FT stress and the heat reversibility are similar for 
all lysozyme formulations tested. For the formulations with 
NaCl and the formulations where PEG200 was added, the 
area was the largest without any FT stress, see Fig. 3b. The 
smaller the calculated SL area, the more the SL is shifted to 
lower protein and salt concentrations. A large SL area indi-
cates high protein solubility and a small aggregation zone in 
the respective phase diagram. In formulations where sucrose 
or Tween20 were added, the area of FT c0 was similar to that 
of FT c1 h. With glycerol, the area with the formulations 
which performed FT c1 h was even larger than for FT c0. 
An overall trend could be observed when the influence of FT 
cycles was taken into account. The more the FT cycles were 
applied to the formulations, the smaller the SL area became. 
In addition, the heat cycle results in a significant increase 
in the SL area for FT c1 and FT c3. The only exception was 
shown with Tween20 formulations. Here, the heat cycle did 
not increase the SL area for FT c1, see Fig. 3b.
Comparing the different excipients to each other, the 
formulations with sucrose addition showed the highest SL 
area values, followed by glycerol formulations, see Fig. 3b. 
These formulations are followed by NaCl, NaCl + PEG200 
and NaCl + Tween20 formulations in the order from high to 
low SL area values.
Dynamic light scattering (DLS)
The protein size of the formulations investigated was meas-
ured performing DLS measurements in triplicate, see Fig. 4. 
No significant changes could be observed. The stress type 
(FT and the heat) and amount (cycle number) did not influ-
ences the protein size. Comparing the results of the different 
formulations to each other, small differences were observed: 
Formulations with NaCl, PEG200, and Tween20 show radii 
in a lower range (app. 2.0–2.5 nm), whereas formulations 
with sucrose or glycerol show radii with approximately 
2.3–3.3 nm. Finally, heat reversibility did not show signifi-
cant alteration in the size of the protein when compared to 
the initial dimensions.
Fourier‑transform infrared spectroscopy (FTIR)
Protein structure information were investigated using 
FTIR. All samples measured with DLS were also ana-
lyzed using FTIR. After data pre-processing (see “Fou-
rier-transform infrared spectroscopy (FTIR)”), the 
spectra is shown in Fig.  5  A. In the interesting amid 
I region where the alpha–helix (1650–1685  cm−1), 
beta–sheet (1615–1635 cm−1) and beta–sheet antiparallel 
(1670–1685 cm−1) structures absorb nearly no differences 
were detected. This becomes clearer when the calculated 
areas for each region are compared to each other, see Fig. 5b. 
With these results, no influence of protein and salt concen-
tration, stress type (FT or heat cycling), FT cycle number, 
and excipients could be determined in this study.
Discussion
In the following section, results are discussed concerning 
the influence of the tested excipients (300 mM sucrose, 
1000 mM glycerol, 6.81 mM PEG200, 0.03 mM Tween20) 
on the long–term protein stability of FT–stressed formula-
tions, as well as whether these changes are reversible by 
adding a heat cycle after the respective FT protocol was 
performed. The results are discussed separately for each 
formulations tested and the respective influence of the heat 
cycle. Finally, a comparison is made across the different 
formulations.
Multidimensional protein phase diagram (MPPD)
The creation of the MPPDs resulted in an information loss of 
only 10% due to data dimension reduction from nine to three 
dimensions. Consulting literature, this falls in an acceptable 
range [36].
The MPPD procedure allowed an automated evaluation 
and clustering providing a rapid overview over a huge data 
set of complex phase transitions taking place in the phase 
diagrams. As shown in Fig. 2 it further provided insight into 
positioning (Fig. 2a) and occurrence (Fig. 2b) of different 
phase states. While clustering as such occurs in an auto-
mated fashion, the choice of suitable descriptors is of course 
subjective and great care needs to be taken when deciding 
on a certain set. Two examples underlining this are seen in 
the current study. The misclassifications seen for Cl I (meant 
to represent soluble formulations only) were due to accom-
modating the high variety of crystal sizes in a single data 
set. The data set included length and width values, which 
are very large (due to sea urchin crystals) and very small 
(due to micro crystals).
With the normalizing step during MPPD creation, the 
small size values close to zero let to an incorporation into 
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Fig. 3  In A the solubility lines of lysozyme in different formulations 
where different stress protocols were applied. The lysozyme concen-
tration in mg/mL is plotted over a varying NaCl concentration in M. 
In B the calculated area of each phase diagram investigated is shown. 
The SL area is plotted over the different formulations tested, the dif-
ferent shades of gray represents FT c0 (darkest gray), FT c1, FT c3, 
FT c1 h, FT c3 h (lightest gray) (color figure online)
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Cl I. In addition, the formulations belonging to a cluster 
do show a distinct distribution and the transition from one 
to another cluster might lead to overlaps. This is visual-
ized in Figure S1 in the Supplementary Material, where 
all 2400 conditions are plotted.
A second issue going hand–in–hand with the above 
findings is the appearance of two different morphologies 
seen for Cl IV and Cl VI, as shown in Fig. 1. Here, the 
reason lies clearly in the similarity of the image-based 
parameters taken into account, namely size and time. This 
shows the care and orthogonality needed when choosing 
descriptors for an automated classification scheme. In 
the present study, a distinction of different morphologies 
could be possibly reached by an addition of the crystal 
intensity, due to the higher intensity of sea urchin crystals 
and the dense micro crystal when compared to tetragonal 
crystals (independent of size).
Nevertheless, a MPPD creation allows an objective 
scoring and clustering of phase diagrams, based on crys-
tal dimensions and other descriptors chosen. In a sec-
ond step, however, the raw data of the created clusters 
needs to be checked to ensure that choice of descriptors, 
overlap, and distribution of features does not lead to a 
false interpretation of data.
Formulations
In the following section, the results obtained for each sys-
tem tested using the MPPD approach are discussed. The 
evaluation of molecular starting conditions, namely the 
DLS and FTIR measurements of the soluble regions chosen 
(Figs. 4, 5) for two different concentrations show no sig-
nificant alteration in measured values as a function of stress 
applied. From this, it can be concluded that the formation 
of different crystal morphologies and thus cluster distribu-
tion is not dependent on structural protein parameter. But it 
should keep in mind that a small fraction of protein might 
undergo partial unfolding and/or aggregation, which is not 
detectable using the described DLS or FTIR measurements. 
These small changes might cause undesirable particle forma-
tion and change in the crystallization kinetics.
The increase in apparent size seen for increasing salt con-
centrations, and respectively higher ionic strengths, within 
a certain formulation subgroup might be due to increasing 
hydrophobic protein–protein interactions [37]. The greater 
Fig. 4  The results of the 151 DLS measurements are shown. The 
NaCl concentration is plotted over the cycle number for the different 
formulations investigated. The upper row shows the results for 21 mg/
mL lysozyme and the lower row for 18  mg/mL. The color bar rep-
resents the apparent hydrodynamic radius in nm. Measurements of 
conditions where the box is marked gray were not possible due to 
aggregation appearance. The respective deviations from the triplicate 
measurements are shown in the “Supplementary Material” Figure S2 
(color figure online)
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Fig. 5  In A the pre–processed FTIR spectra for all 151 samples, 
which performed also the DLS measurements, are plotted (see 
Fig. 4). The range between a wave number of 1650 and 1685 cm−1 
represents alpha–helix structure, 1615 and 635  cm−1 beta–sheet 
structures, and 1670 and1685  cm−1 beta–sheet antiparallel struc-
tures. In B the calculated areas of the interesting regions for alpha–
helix (top), beta–sheet (middle) and beta–sheet antiparallel (bottom) 
are shown for all measured samples (Sample no. 1–8: NaCl; 9–16: 
NaCl + sucrose; 17–24: NaCl + glycerol; 25–32: NaCl + PEG200; 
33:40: NaCl + Tween20). Blue dots represent 0 cycles, red points 1 
cycle, yellow dots 3 cycles, purple dots 1 cycle heat, and green dots 3 
cycle heat (color figure online)
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the protein–protein interactions, the lower the molecule 
diffusion in the solutions and the bigger the hydrodynamic 
radius estimated by DLS measurements [38]. The slightly 
higher apparent radii of sucrose and glycerol formulations 
can be explained by an overall increased viscosity, due to 
the high excipient concentrations used, and the procedure of 
how the hydrodynamic radius is estimated (Stokes–Einstein 
equation) [38, 39].
The respective excipients were chosen due to their dif-
ferent protein interaction mechanism, which are explained 
in the following.
Salt
Using NaCl as an additive only, the salt concentration mainly 
modulates electrostatic interactions and suppressing these 
allows hydrophobic interactions to play a more dominant 
role. Lysozyme with a pI of 11.35 [40] is positively charged 
at the operating pH of pH 5. Given this, the distance to its 
pI seems wide enough so that a slight change in pH will not 
result in changes of surface charge and effects seen can be 
related to alteration in additive solely. The concentration 
range from 0 to 1.1 M NaCl was chosen due to the ability of 
stabilizing or destabilizing the protein stability depending 
on the protein surface charge and the salt concentration [41].
Osmolytes
Two different osmolytes were chosen in this study, due to 
their ability to stabilize the native structure of the protein 
upon environmental stress [42–44] and thus also act as cryo-
protectants. The osmolytes used in this study are sucrose 
[45, 46], a sugar, and glycerol [43, 47], a polyol.
Sucrose Sucrose is known to be an effective cryoprotectant, 
due to stabilizing the native structure of proteins by ther-
modynamic stabilization. Thereby, preferential exclusion of 
sucrose and subsequently hydration of the protein surface 
are taking place [48].
Glycerol The mechanisms triggered by adding glycerol are 
not completely understood. The most significant contribu-
tions are twofold. There is preferential exclusion effect of 
glycerol, comparable with sucrose, where the native protein 
structure is stabilized. Furthermore, stabilization of glycerol 
is assumed to be also due to preferential interaction of glyc-
erol and the hydrophobic regions on the protein surface and 
following the inhibition of protein unfolding [47].
Polymers Polymers are also known to generally stabilize 
protein solutions [30, 49], whereas the mode of action is 
strongly dependent on their molecular weight [50] and con-
centration applied [51]. Low molecular weight PEG present 
in low concentrations may induce protein stabilization due to 
the steric shielding of attractive protein–protein interactions 
[44, 51]. This effect is exploited in this study using 6.81 mM 
(6 w/w%) PEG200. Depending on the hydrophobicity of the 
protein surface, the mechanism of PEG is influenced. When 
the protein surface is hydrophobic, destabilizing preferen-
tial interaction of the hydrophilic PEG molecules and the 
hydrophobic patches on the protein surface is taking place. 
Otherwise, like in this study where the protein surface is 
positively charged, stabilizing preferential exclusion of the 
PEG molecules is taken place [49].
Surfactant Finally surfactants, and in this group of excipi-
ents especially Tween20 and Tween80 are commonly used, 
due to their ability to stabilize protein stability against 
freeze stress–induced aggregation [20, 52]. In this study, 
0.03 mM of Tween20 was chosen. The chosen concentra-
tion was distinctly below the critical micelle concentration 
(CMC) of 0.57 mM [53] to potentially prevent surface loss 
and aggregation [54]. Surfactants are known to interact with 
the hydrophobic regions on the protein surface [54–56]. In 
addition, surfactants are also known to prevent the unfold-
ing of the protein on hydrophobic surfaces such as air–water 
[57].
Initial state–FT c0
Using NaCl as an additive, the salt concentration influenced 
the phase behavior, the aggregation kinetics, the crystal mor-
phology, and the radius of lysozyme. Here we clearly see 
the interplay of electrostatic and hydrophobic interactions. 
In short, at lower salt concentrations, long–range repul-
sive electrostatic protein interactions are significant [33, 
58]. These forces are reduced by the presence of salt ions 
and short–range attractive forces become dominant, which 
results in aggregation [22, 37, 59, 60]. Consequently, at low 
NaCl concentrations (< 300 mM), a salting–in (stabilizing) 
effect and at high NaCl concentrations, a salting–out (desta-
bilizing) effect was observed [41].
The salt concentration not only determined protein solu-
bility but also influenced the crystal morphology. The aggre-
gation zone occurs adjacent to Cl I, representing the soluble 
zone. This zone is often referred to as the labile or crystalli-
zation zone; here, the energy barrier to create nuclei is over-
come and crystal growth can occur [8]. As the appearance 
of Cl II and Cl III corresponded to this zone, they showed 
similar crystal sizes but the growth time differs.
For Cl III the growth time (tG) is smaller, however, this 
cluster was mainly seen for higher lysozyme concentra-
tions, thus a higher supersaturation [61] and as a conse-
quence enhanced creation of critical nuclei [62, 63]. Higher 
supersaturation is assumed to correlate to shorter growth 
time, which results of crystal growth to bigger sizes. Bigger 
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crystals were not reached in the phase diagram, here, it 
is assumed that the concentration steps of lysozyme and 
NaCl were too huge to reach this zone after Cl II and Cl 
III appeared. Instead, the supersaturation was too high for 
supporting crystal growth but with increasing salt concentra-
tions and high protein concentrations, resulted in an increase 
in the amount of crystals and a decrease in crystal size [61, 
64, 65], corresponding to Cl IV and Cl V, see Table 1. At 
very high lysozyme and NaCl concentrations, the supersatu-
ration reaches a level where the growth of unstable poly-
morph crystals (sea urchin crystals) is promoted [17, 66]. 
This morphology is represented partly by Cl VI and mainly 
by Cl VII.
When adding sucrose representing the group of osmolytes 
to the salt containing systems at FT c0 a slightly higher 
lysozyme solubility was reached, whereas the size of the 
aggregation zone slightly decreased. Subsequently, a small 
stabilizing effect can be attributed, due to the mentioned 
preferential exclusion of sucrose [48].
Regarding cluster positioning and occurrence, the transi-
tion to the soluble zone seems unaltered, while the aggrega-
tion shape changed to smaller crystals (from Cl III to Cl IV) 
at higher protein and medium NaCl concentrations, when 
sucrose was added. The supersaturation level is high enough 
to create critical nuclei but due to preferential exclusion of 
sucrose, the growth time (tG) is reduced, which results in a 
higher amount of small crystals. In addition, at higher NaCl 
concentrations, the zone of Cl VII is larger adding sucrose 
to the formulations when compared to pure NaCl formula-
tions. This might be due to the higher viscosity of sucrose 
formulations in this region compared to pure NaCl formula-
tions. The viscosity of a 300 mM sucrose solution (~ 10 w/w 
%) at 25 °C is 1.31 mPas which is higher than the viscosity 
of pure water at 25 °C of 0.89 mPas [67]. Due to the lower 
nucleation rate, high supersaturation in these formulations 
and the formation of temporary LLPS, sea urchin crystals 
grow preferably in this region [17, 66].
Comparable to the addition of sucrose, we see an increase 
of Cl I (soluble region) when adding glycerol. A higher vis-
cosity of the formulation might also explain the increas-
ing amount of small crystal sizes at intermediate salt con-
centrations. The viscosity at 25 °C of a 1000 mM glycerol 
(~ 9 w/w%) solution is slightly lower (1.15 mPas) compared 
to a 300 mM sucrose formulation (1.31 mPas) [67]. The 
cluster formation only differed in the high-salt region com-
pared to sucrose formulations. No sea urchins (Cl VI or 
Cl VII) appeared with glycerol formulations, see Fig. 2a, 
C 3. Glycerol seems to influence the nucleation rate in this 
region. Nevertheless, due to the still very high nucleation 
rate micro crystals grow (Cl IV).
PEG200 representing the group of polymers is known to 
be preferentially excluded. However, according to the size 
of the aggregation zone, lysozyme solubility, and cluster 
formation, no significant changes were observed compared 
to the pure NaCl formulations. In the applied concentra-
tion (as compared to protein and salt concentration present) 
PEG200 is probably to low concentrated for non-stressed 
conditions to lead to a significant change. Due to NaCl 
attractive protein–protein interactions occur, which can be 
shielded by the PEG molecules. However, in this case it is 
assumed that the attractive protein–protein interactions are 
too present and/or the PEG concentration is too low to sta-
bilize lysozyme. A higher PEG concentration or molecule 
weight is assumed to be more effective [50, 51].
Finally, the influence of surfactants was probed by add-
ing Tween20. The protein phase behavior was not changed 
significantly by the addition of Tween20, but the morphol-
ogy and the protein solubility differ compared to pure NaCl 
formulations. The interaction of Tween20 probably resulted 
in lower protein solubility, and the SL area showed smaller 
values, see Fig. 3b, due to the shifted equilibrium between 
monomer and aggregated proteins towards aggregated pro-
teins. The interaction of Tween20 with the hydrophobic 
patches on the protein surface [54–56] might have resulted 
in a significant cluster formation of Cl V, indicating micro 
crystals. It can be assumed that, due to the interaction of 
Tween20 on the protein surface, the formation of bigger 
tetragonal crystals is inhibited. Finally, unfolding on hydro-
phobic water–air interfaces seems to be not a problem for 
lysozyme in this study and subsequently, no stabilizing by 
Tween20 at FT c0 could be observed.
FT cycle–FT c1 and FT c3
The unmet ability of the MPPD approach to visualize posi-
tioning (Fig. 2a) and occurrence (Fig. 2b) of cluster trans-
formation can also be seen in the development of cluster 
during FT cycling. In general, all tested excipients had 
an impact on the MPPD and the SL area compared to the 
pure NaCl formulations. In the following, the potential 
mechanistic processes occurring (shielding attractive pro-
tein–protein interactions, preferential hydration, and the 
stabilization of the native state) and thus being the driver 
behind the cluster transformations during FT cycling are 
discussed. For all tested excipients, a reduction of Cl I is 
seen and can be linked to freeze concentration effects expe-
rienced during FT cycling. Freeze concentration results in 
an increase of supersaturation, leading to an increase in the 
concentration of all solutes, such as buffer components, 
excipient, and proteins, due to the formation of ice crystals 
[11, 17]. This results in protein aggregation [12, 13] and 
subsequently, the protein solubility is lowered due to the 
shifted aggregate/monomer equilibrium towards aggre-
gates, which was observed with the solubility lines, see 
Fig. 3b. In addition to the effect of freeze concentration, 
the decrease in Cl I can also be attributed to the repetition 
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of the FT stress effects as such. In combination, next to 
freeze concentration [11, 17], temperature-induced LLPS 
[9, 17, 18] and denaturation on the water–ice interface 
[7, 20] might take place. Among these effects, however, 
denaturation on the water–ice interface can be excluded, at 
least for the measured samples, due to the shown similarity 
of the FTIR spectra to those of FT c0 (Fig. 5).
A cluster transformation towards a higher portion of 
Cl  IV and shift towards lower salt concentrations was 
shown for NaCl formulation (and all other systems dis-
cussed below), when FT stress was applied, see Fig. 2. 
This indicates a change to more and smaller crystals, 
pointing towards a freeze concentration effect. The nuclea-
tion rate of crystals depends on the degree of supersatura-
tion [68]. Due to freeze concentration, the supersatura-
tion is increased and consequently, the nucleation rate is 
increased as well. For pure NaCl systems, above 1.82 M 
mainly Cl VI and Cl VII appeared, indicating a shift to 
sea urchin crystals. It can be assumed that the initial vis-
cosity in these formulations (due to temperature [69] and 
protein concentration) was very high leading to a lower 
diffusion rate, which in return results in a lower nucleation 
rate [70]. Next to the lower nucleation rate, high super-
saturation, as well as temporary LLPS, is another prereq-
uisite for the growth of sea urchin crystals [17, 66]. The 
application of FT stress to sucrose formulations resulted 
in an overall lower decrease in protein solubility. Thus, 
the known effectiveness of sucrose as a cryoprotectant 
could be confirmed with these observations [45, 46]. The 
dominating cluster formation of Cl V and Cl VI and spread 
towards lower excipient concentrations mimics the above 
stated line of argumentation, namely an increase in the 
nucleation rate due to freeze concentration [17, 62, 66, 
68]. For glycerol containing systems, FT stress applica-
tion resulted in a smaller occurrence of Cl I and a decrease 
in solubility, but less significant than for NaCl formula-
tions, see Figs. 2b and 3b. Subsequently, glycerol was as 
expected able to stabilize lysozyme regarding FT stress. 
The intermediate cluster transition from small (Cl IV) to 
bigger (Cl II) crystals seen for FT c1 took place at protein 
concentrations below 2 mg/mL lysozyme. This might be 
an indication for a situation where FT stress is no yet the 
dominating factor and the addition of glycerol resulted in 
slower aggregation kinetics and larger crystals [35]. When 
performing the FT cycles three times the observed clus-
ter formation of Cl VI and its positioning resembled the 
above-described dominant situation. PEG200 showed no 
stabilizing effect, seen in the decrease of Cl I, compared 
to the NaCl formulations. Overall, as found for the other 
systems, the scheme of a dominant growth of Cl IV is seen 
and due to the above-described combination of FT stress. 
The systems containing Tween20 already started with a 
dominating Cl V. With an increase in FT stress, a clear 
decrease in Cl I was observed pointing towards the inabil-
ity of the current formulation to act as stabilizing formula-
tion under the given conditions. This is underlined by the 
most dominant appearance of Cl IV during FT cycling 
over the whole aggregation zone.
Overall, the highest values of the calculated SL area were 
reached with the osmolytes tested (sucrose and glycerol) 
due to preferential hydration of the surface and minimized 
protein–protein interactions. The smaller the protein–protein 
interactions, the higher the solubility [23, 35]. Consequently, 
sucrose and glycerol are the excipients that were able to sta-
bilize lysozyme the most regarding solubility and size of 
the solubility zone during FT cycling. PEG did not change 
stability significantly. For all systems investigated the addi-
tion of Tween20 led to destabilization when compared to 
pure NaCl containing systems, which is probably due to the 
applied concentration.
Heat cycle–FT c1 h and FT c3 h
When applying heat cycling after FT cycling a clear clus-
ter transformation and thus reversibility of already formed 
aggregates resulting in a decrease of Cl IV and increase in 
Cl I as well as an increase in protein solubility (Fig. 3) was 
seen. This clearly shows that heat cycling might be applied 
to exploit the reversibility of aggregates formed not only 
during FT cycling but also during general processing, i.e. 
other unit operations creating aggregates. In general, mainly 
Cl IV areas transformed back to Cl I, but also Cl II and 
Cl III. In common to these clusters is either no tonset for Cl I 
(fully soluble area) or tonset > t0 for Cl II and Cl III, whereas 
the other clusters (Cl IV–Cl VII) showed aggregates from 
the beginning when the plates were pictured the first time 
tonset = t0. The heat-induced reversibility is assumed to lead 
to a reset of the reversible systems and new arrangement of 
crystals independent of and undisturbed by stress resulting 
from FT or heat cycling.
A potential cause for a reset of systems – in this study 
mainly systems lying in the metastable zone containing 
reversible aggregates by heat cycling might be that the 
applied heat / energy input was high enough to loosen pro-
tein–protein interactions (only weak non–covalent protein 
interactions) [26], but also low enough not to induce heat 
aggregation and/or unfolding [28]. In this context, it is 
assumed that aggregates in the lower supersaturated region 
(adjacent to Cl I) created weak protein–protein interactions 
and, therefore, those are able to dissolve by heat [26], and 
consequently the same clusters are created than without FT 
stress or heat.
The good reversibility found for the osmolyte systems 
containing sucrose or glycerol is assumed to relate to weak 
protein–protein interactions [26, 69] and thus potentially 
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reversible, due to the preferential hydration of the protein 
surface supported by the excipients.
Also for the PEG200 systems, heat-induced reversibility 
was observed. However, the effect was found not as sig-
nificant as for NaCl formulations. On the contrary, PEG200 
molecules seemed to stabilize the aggregates, which 
occurred due to the FT stress. The reason for this might be 
based on the overall higher polymer concentrations in solu-
tion due to freeze concentration, resulting in a displacement 
of the PEG molecules from between the protein molecules 
instead of steric stabilization [71]. Hence, the restructuring 
of the PEG molecules seems to be not completely reversible. 
For Tween20 formulations, the heat cycle only influences 
the occurrence of Cl I and the overall protein solubility. 
The protein solubility could be completely reversed by heat 
(Fig. 2b). The occurrence of Cl I, representing the soluble 
zone, was not completely reversed to the size observed at 
FT c0, but most of the FT stress-induced aggregates dis-
solved when heat was applied, see Fig. 2b.
In summary, the best performance (increase of Cl 1) in 
the heat-induced reversibility showed glycerol-containing 
systems. The follow-up systems were sucrose, pure NaCl and 
the Tween20 systems (the latter showing a reduced revers-
ibility for increasing FT cycling). The lowest effect on heat-
induced reversibility was seen for the PEG200 containing 
systems.
Conclusion
In this study, the effects of instabilities induced by FT stress 
(up to three cycles) and the reversibility of those instabilities 
induced by heat cycling on the long-term (MPPD,SL) and 
short-term protein stability (size and structure) were investi-
gated using lysozyme as an exemplary protein. It was shown 
that a re-set of areas consisting of reversible aggregates 
could be reached by heat cycling. This led to a resolution of 
reversible aggregates. The influence of different well-known 
cryoprotectants (sucrose, glycerol, PEG200 and Tween20) 
showed that the degree of instabilities and reversibility of 
aggregates was formulation dependent. The effects of FT-
induced instabilities and their reversibility by heat-cycling, 
depending on the different formulations, can be summed up 
as follows: The addition of sucrose and glycerol resulted in 
the best performance as cryoprotectant. Regarding aggre-
gate reversibility (increase in Cl I) glycerol performed best, 
followed by sucrose, NaCl and Tween. Finally, the use of 
MPPD to study the complexity and interplay of different for-
mulations and processing situations showed to be excellent 
in terms of data visualization. In future work, the influence 
of heat cycling on reversible aggregation will be investi-
gated. Furthermore, different formulation parameters like 
pH value, salts, cryoprotectants and buffer systems need to 
be investigated. The transfer to other protein molecules and 
also to highly concentrated protein formulations is manda-
tory for applications in industry. Finally, the addition of a 
heat cycle might be an effective tool to minimize instabilities 
throughout general processing.
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